[Hematocrit as an indicator for coronary intervention in patients with acute myocardial infarction]

Fumitaka Inoue1, Toshio Hashimoto, Hisayuki Tabuse

  • 1Nara Prefectural Emergency and Critical Care Center, Hiramatsu 1-30-1, Nara, Nara 631-0846.

Journal of Cardiology
|January 16, 2004
PubMed

Insights

High hematocrit levels in acute myocardial infarction patients correlate with more difficult primary coronary interventions due to increased thrombus formation. Measuring hematocrit is crucial for guiding intervention strategies in these critical cases.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Hematology

Background:

  • Primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) can be challenging, particularly with significant intracoronary thrombus.
  • Elevated hematocrit levels have been anecdotally linked to increased thrombus burden during AMI.

Purpose of the Study:

  • To investigate the association between high hematocrit score and the difficulty of primary PCI in patients experiencing AMI.
  • To determine if hematocrit levels predict the presence of massive intracoronary thrombus and procedural complexity.

Main Methods:

  • Forty-five AMI patients were stratified into high (hematocrit >= 48%) and low (< 48%) hematocrit groups.
  • Key procedural metrics including intervention time, balloon inflations, thrombus presence, need for adjunctive thrombolysis, intra-aortic balloon pumping, and Thrombolysis in Myocardial Infarction (TIMI) 3 flow were compared.
  • Correlation analyses explored relationships between hematocrit and intervention time or balloon inflations.

Main Results:

  • The high hematocrit group exhibited significantly longer intervention times (2.7 vs 1.4 hr), more balloon inflations (12 vs 3), 100% incidence of massive thrombus, and higher rates of adjunctive thrombolysis (63%) and intra-aortic balloon pumping (63%).
  • Conversely, TIMI 3 flow was markedly lower in the high hematocrit group (25% vs 95%).
  • Positive correlations were found between hematocrit and both intervention time (r2=0.16) and balloon inflations (r2=0.19).

Conclusions:

  • High hematocrit on admission in AMI patients is associated with a greater likelihood of persistent massive intracoronary thrombus, complicating primary PCI.
  • Measurement of hematocrit score should be incorporated into the interventional strategy for AMI patients undergoing primary coronary intervention.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...